Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXFK3U
|
||||
Drug Name |
N-(6-cyano-1-((1-methyl-1H-imidazol-5-yl)methyl)-1,2,3,4-tetrahydroquinolin-3-yl)-1-methyl-N-(2-methylallyl)-1H-imidazole-4-sulfonamide
|
||||
Synonyms |
CHEMBL181102
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C23H27N7O2S
|
||||
Canonical SMILES |
CC(=C)CN(C1CN(Cc2cncn2C)c3ccc(cc3C1)C#N)S(=O)(=O)c4cn(C)cn4
|
||||
InChI |
InChI=1S/C23H27N7O2S/c1-17(2)11-30(33(31,32)23-14-27(3)16-26-23)20-8-19-7-18(9-24)5-6-22(19)29(12-20)13-21-10-25-15-28(21)4/h5-7,10,14-16,20H,1,8,11-13H2,2-4H3
|
||||
InChIKey |
JNJBXYHGNTUTTK-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.